Pharma Marketletter

Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.

VdAk drug estimates.(Verband der Angestellten-Krankenkassen )(Brief Ar...
May 30, 2005

Nutrition 21's Diachrome improves cardiovascular risk factors in type ...
May 30, 2005

Vits E and C shown to be safe at high dose.(Brief Article)
May 30, 2005

Novartis' Diovan cuts diabetes risk.(Brief Article)
May 30, 2005

Zelnorm's potential for GI disorders revealed.(GastroIntestinal)
May 30, 2005

Imclone's Erbitux shows increased survival in head and neck cancer.
May 30, 2005

Bayer and Asklepios reach hemophilia deal.(Asklepios Biopharmaceutical...
May 30, 2005

Santaris initiates PhI/II trial of SPC2996.(Brief Article)
May 30, 2005

Melanotan gives strong Ph I/II performace.(Brief Article)
May 30, 2005

Enkam's neuroprotectant finishes Ph I.(Brief Article)
May 30, 2005

Fournier's Anatibant gets US Orphan status.(Brief Article)
May 30, 2005

MedImmune's Numax sees good Ph I/II.(Brief Article)
May 30, 2005

Expanded indication for AstraZeneca's Atacand.(Brief Article)
May 30, 2005

Chiron and Enanta start HCV collaboration.(Brief Article)
May 30, 2005

Humira: strong results against Crohn's disease.(Brief Article)
May 30, 2005

BioXell and Merck & Co enter TREM accord.(Brief Article)
May 30, 2005

Bayer/Onyx' sorafenib doubles progression-free survival in RCC.(Brief ...
May 30, 2005

Sanofi-Aventis' Taxotere provides survival benefit in gastric cancer.(...
May 30, 2005

Antisoma's AS1411 shows promise as cancer treatment.(Brief Article)
May 30, 2005

Revlimid found to prolong time to progression of multiple myeloma.(Bri...
May 30, 2005

Encouraging Phase II results for Oxford Biomedica's TroVax.(Brief Arti...
May 30, 2005

GSK's Rotarix effective in children under two.(GlaxoSmithKline)
May 30, 2005

Positive results for AstraZeneca's Seroquel.
May 30, 2005

R&M releases new report on blockbusters.(Research and Markets)
May 30, 2005

Medical specialists help access opinion makers.(Brief Article)
May 30, 2005

Average drug marketing cost now reaches $54.5M.(Brief Article)
May 30, 2005

NKRF kick-starts UK renal patient network.(National Kidney Research Fu...
May 30, 2005

Asthma costs slashed through better management, study says.(Brief Arti...
May 30, 2005

Weak performance at TAP takes its toll on Takeda's FY to March 2005.(T...
May 30, 2005

The future of life science industries; Deliotte survey.
May 30, 2005

$77 billion annually in lost income attributed to ADHD in the USA.(Att...
May 30, 2005

CA firms' nightmare on compliance laws.(California)(Brief Article)
May 30, 2005

California Rx assist program a success.(Brief Article)
May 30, 2005

Japan stock market week to May 23.
May 30, 2005

Ligand to restate financial results.(Brief Article)
May 30, 2005

Matrixx extends cold/cough OTC products.(Brief Article)
May 30, 2005

Biotech announces ad campaign for Sucanon.(Brief Article)
May 30, 2005

Rincon and Biogen Idec form research alliance.
May 30, 2005

Boeh Ingel: strong data for MicardisPlus.(Brief Article)
May 30, 2005

Alliance explores Oxygent proof-of-concept study.(Brief Article)
May 30, 2005

Enanta and Chiron enter HCV R&D accord.(hepatitis C virus)(Brief Artic...
May 30, 2005

Nymox's TobacAlert to be marketed in US schools and industry.(InnerLin...
May 30, 2005

Georgian Rx output up.(Brief Article)
May 30, 2005

US FDA Drug Safety Oversight Board named.(Food and Drug Administration...
May 30, 2005

Combating fake drugs: US FDA annual update.(Food and Drug Administrati...
May 30, 2005

IFPMA launches clinical trial search portal.(International Federation ...
May 30, 2005

Philippines lawmakers urge Rx price regulation.(City Council of Cebu )...
May 30, 2005

EU generic drugs market overview.(European Union)(Industry Overview)
May 30, 2005

Corgenix comples $5.1M placing.(Brief Article)
May 30, 2005

Tercica prevails in UK court ruling.(Brief Article)
May 30, 2005

Wilex' Rencarex extends survival in metastatic RCC.(Brief Article)
May 30, 2005

Myriad licenses tech to Salmedix for cancer drugs.(Brief Article)
May 30, 2005

Merck KGaA relocates Scottish research unit to USA.
May 30, 2005

GSK's Coreg granted additional labelling by US FDA.(Brief Article)
May 30, 2005

Isis and Pfizer collaborate on eye disease antisense treatments.(Brief...
May 30, 2005

The FDA has rejected Johnson & Johnson's Risperdal for autism.(Food an...
May 30, 2005

Vical licenses HGF technology to AnGes MG.(Brief Article)
May 30, 2005

Chiltern Int names Catherine Lemercier manager, marketing North Americ...
May 30, 2005

Praecis cuts workforce 60% in reshuffle.(Brief Article)
May 30, 2005

Turbulent times for Able Laboratories.(Brief Article)
May 30, 2005

Epimmune's 1st-qtr 2005 net loss rockets.(Brief Article)
May 30, 2005

Medarex' 1st-qtr sales soar, but loss grows.(Brief Article)
May 30, 2005

SPECTRUM.(Illustration)
May 30, 2005

Stock Commentary - Europe.(Brief Article)
May 30, 2005

Stock Commentary - New York.
May 30, 2005

BI/Pfizer's Spiriva improves quality of life in COPD.(Brief Article)
May 30, 2005

Positive data for Genentech/Novartis Lucentis in AMD.
May 30, 2005

Pharmacopeia gets milestone payment from Organon.(Brief Article)
May 30, 2005

Cytheris gets rights to immuno-modulating agent.(Brief Article)
May 30, 2005

Alvesco does not affect short-term growth, study finds.(Brief Article)
May 30, 2005

Curagen and TopoT publish strong Ph I results for PXD101.(Brief Articl...
May 30, 2005

Inpharmatica launches GPCR database.(Brief Article)
May 30, 2005

CuraGen's Velafermin is tolerated in OM.(Brief Article)
May 30, 2005

Bionaut and NCI sign cancer R&D accord.(National Cancer Institute)(Bri...
May 30, 2005

Xanthus' Xanafide sees good safety data.(Brief Article)
May 30, 2005

Page 1|2|3|4|5|6|7|8|9|10